World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
8823
World Ranking
4517
National Ranking
192

Overview

Paolo Airò is affiliated with the University of Brescia in Italy and has a research focus primarily within the field of Medicine. Their work spans numerous specialized subfields including Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Epidemiology, Dermatology, and Rheumatology.

The scientist's research topics cover a range of clinical and biomedical areas. These include:

  • Systemic Sclerosis and Related Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Inflammatory Myopathies and Dermatomyositis
  • Dermatologic Treatments and Research
  • COVID-19 Clinical Research Studies
  • Inflammasome and Immune Disorders
  • Skin Diseases and Diabetes

Paolo Airò has contributed to several recent papers that address key medical challenges, particularly in rheumatology and pulmonary conditions. Selected recent publications include:

  • Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy (2020), published in Autoimmunity Reviews
  • Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database (2020), published in Annals of the Rheumatic Diseases
  • Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome (2020), published in Annals of the Rheumatic Diseases
  • COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study (2020), published in The Lancet Rheumatology
  • Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers (2022), published in Clinical Reviews in Allergy & Immunology

Frequent co-authors collaborating with Paolo Airò include:

  • Oliver Distler
  • Maria Grazia Lazzaroni
  • Franco Franceschini
  • Yannick Allanore
  • Marco Matucci-Cerinic

Paolo Airò's research appears regularly in established publication venues such as:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Clinical and Experimental Rheumatology
  • The Lancet Rheumatology
  • Journal of Scleroderma and Related Disorders

Best Publications

  • Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    Anthony J. Tyndall;Bettina Bannert;Madelon Vonk;Paolo Airò

  • Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.

    Paola Toniati;Simone Piva;Marco Cattalini;Emirena Garrafa

  • Mapping and predicting mortality from systemic sclerosis

    Muriel Elhai;Christophe Meune;Marouane Boubaya;Jérôme Avouac

  • Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    Jérôme Avouac;J. Fransen;U. A. Walker;V. Riccieri

  • Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Suzana Jordan;Jörg H W Distler;Britta Maurer;Dörte Huscher

  • Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Timothy R.D.J. Radstake;Olga Y Gorlova;Blanca Rueda;Jose Ezequiel Martin

  • Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies

    Jérôme Avouac;Paolo Airò;Christophe Meune;Lorenzo Beretta

  • Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.

    Anna-Maria Hoffmann-Vold;Yannick Allanore;Margarida Alves;Cathrine Brunborg

  • Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis

    Y. Allanore;C. Meune;M. C. Vonk;P. Airo

  • Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

    Veronika K. Jaeger;Elina G. Wirz;Yannick Allanore;Philipp Rossbach

  • Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis.

    Yannick Allanore;Yannick Allanore;Mohamad Saad;Philippe Dieudé;Jérôme Avouac;Jérôme Avouac

  • Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

    Olga Gorlova;Jose Ezequiel Martin;Blanca Rueda;Bobby P C Koeleman

  • Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

    Maureen D. Mayes;Lara Bossini-Castillo;Olga Gorlova;José Ezequiel Martin

  • Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study

    Muriel Elhai;Marine Meunier;Marco Matucci-Cerinic;Britta Maurer

  • Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

    Lorenzo Cavagna;Laura Nuño;Carlo Alberto Scirè;Marcello Govoni

  • Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

    Muriel Elhai;Marouane Boubaya;Oliver Distler;Vanessa Smith

  • The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population

    Raphael Borie;Bruno Crestani;Philippe Dieude;Hilario Nunes

  • Digital ulcers predict a worse disease course in patients with systemic sclerosis.

    Carina Mihai;Robert Landewé;Désirée van der Heijde;Ulrich A Walker

  • Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.

    Mirko Scarsi;Silvia Piantoni;Enrico Colombo;Paolo Airó

  • Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms.

    Elisabetta Danieli;Paolo Airò;Lorenzo Bettoni;Massimo Cinquini

  • Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.

    Maria-Grazia Lazzaroni;Ilaria Cavazzana;Enrico Colombo;Rucsandra Dobrota

  • COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study.

    Micaela Fredi;Ilaria Cavazzana;Liala Moschetti;Laura Andreoli

  • Systemic sclerosis: state of the art on clinical practice guidelines.

    Vanessa Smith;Vanessa Smith;Carlo Alberto Scirè;Rosaria Talarico;Paolo Airo

  • A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5

    Duilio Brugnoni;Paolo Airò;Giuseppe Rossi;Alessandra Bettinardi

  • Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study.

    Mara Taraborelli;Véronique Ramoni;Antonio Brucato;Paolo Airò

  • "High-dose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides.

    Cristina Zane;Carla Leali;Paolo Airò;Giuseppe De Panfilis

  • A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study

    Muriel Elhai;Jérôme Avouac;Ulrich A. Walker;Marco Matucci-Cerinic

  • Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial

    Piero Ruscitti;Francesco Masedu;Saverio Alvaro;Paolo Airò

Frequent Co-Authors

Yannick Allanore
Yannick Allanore Université Paris Cité
Angela Tincani
Angela Tincani University of Brescia
Franco Franceschini
Franco Franceschini University of Brescia
Marco Matucci-Cerinic
Marco Matucci-Cerinic University of Florence
Oliver Distler
Oliver Distler University of Zurich
Eric Hachulla
Eric Hachulla University of Lille
Valeria Riccieri
Valeria Riccieri Sapienza University of Rome
Ilaria Cavazzana
Ilaria Cavazzana University of Brescia
Gabriela Riemekasten
Gabriela Riemekasten University of Lübeck
Christopher P. Denton
Christopher P. Denton University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers, many of which offer flexible online education options. For those interested in entering nursing without prior experience, online ADN programs for non nurses provide a practical starting point. These programs accommodate beginners eager to build foundational nursing skills.

Accelerated paths are also available, especially for individuals seeking to transition quickly into registered nursing roles. Programs like absn programs with high acceptance rates offer an accessible route to earn a Bachelor of Science in Nursing, often designed to fit busy schedules.

For those considering practical nursing, exploring easy lpn programs to get into can help identify the most approachable options. These programs are typically shorter and can lead to valuable entry-level nursing roles, which can be a stepping stone towards specialization.

Advanced practice roles like nurse practitioners are critical in immunology-linked healthcare settings. Investigating easiest online nurse practitioner programs reveals convenient paths for nurses who wish to advance their credentials and impact patient care on a higher level.

Best Scientists Citing Paolo Airò

Trending Scientists

Recently Published Articles